Adherence to prophylaxis and bleeding outcome: A multicenter Nigerian study
暂无分享,去创建一个
S. Yuguda | D. Gwarzo | T. Nwagha | H. Okoye | N. Osuji | C. E. Udo | M. K. Ogunfemi | Dalha H Gwarzo | Christiana Enefiok Udo | Nnamdi Joel Osuji
[1] J. Sathar,et al. Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention , 2021, Healthcare.
[2] S. Israels,et al. Hemophilia prophylaxis adherence and bleeding using a tailored, frequency‐escalated approach: The Canadian Hemophilia Primary Prophylaxis Study , 2020, Research and practice in thrombosis and haemostasis.
[3] G. Auerswald,et al. Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment , 2017, British journal of haematology.
[4] R. Sudevan,et al. Low‐dose prophylaxis for children with haemophilia in a resource‐limited setting in south India—A clinical audit report , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.
[5] J. Gill,et al. Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project. , 2017, Blood.
[6] H. Elmahmoudi,et al. Low dose prophylaxis in Tunisian children with haemophilia , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.
[7] V. Blanchette,et al. When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH , 2016, Journal of thrombosis and haemostasis : JTH.
[8] M. Schuurmans,et al. Promoting self‐management and adherence during prophylaxis: evidence‐based recommendations for haemophilia professionals , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.
[9] R. Furlan,et al. Adherence to prophylaxis is associated with better outcomes in moderate and severe haemophilia: results of a patient survey , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.
[10] R. Ljung,et al. Definitions in hemophilia: communication from the SSC of the ISTH , 2014, Journal of thrombosis and haemostasis : JTH.
[11] R. Ljung,et al. Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. , 2013, Blood.
[12] J. Astermark,et al. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life , 2012, European journal of haematology.
[13] W. Kronenberger,et al. VERITAS‐Pro: a new measure of adherence to prophylactic regimens in haemophilia , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.
[14] H. M. van den Berg,et al. A survey of adherence to haemophilia therapy in six European countries: results and recommendations , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.
[15] Alan R. Cohen,et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.
[16] K. Lindvall,et al. Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[17] M. Manco‐Johnson,et al. Barriers to compliance with prophylaxis therapy in haemophilia , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[18] J. Astermark,et al. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized , 1999, British journal of haematology.
[19] H. Pettersson,et al. Haemophilia prophylaxis in young patients–a long‐term follow‐up , 1997, Journal of internal medicine.